Health insurers directory 2026

    Health Insurance Companies in Turkey

    Almost every resident of Turkey already has a public payer — the Social Security Institution — so the commercial medical market is a complementary layer: Tamamlayıcı Sağlık Sigortası (TSS) that picks up private-hospital difference fees, and a thinner full private product (ÖSS) for people who want to step outside SGK tariffs.

    Allianz Türkiye, Anadolu Sigorta, Aksigorta, Mapfre, Türkiye Sigorta and Acıbadem Sigorta write most of those complementary and full-private cards. SEDDK, the insurance and private-pension authority, rewrote the private-health rulebook from 1 January 2026, including a standardised lifetime-renewal promise. SGK remains the volume payer through the Health Implementation Communiqué (SUT) and contracts with both Ministry city hospitals and private chains. Acıbadem and MLP Care appear here as operator accounts because their network status on a TSS card is what the product is actually selling. This directory is for a brand or access team that must tell an SGK SUT claim from an Allianz or Anadolu top-up, not for a shopper comparing outpatient copays in Kadıköy.

    Updated September 2026 · SEDDK — private health insurance (TSS/ÖSS) supervision, with SGK as the public tariff payer as of September 2026 · 16 named accounts

    Request a proposal for TurkeyBrowse the 16 companies

    ~99%

    Residents on SGK general cover — the public core every TSS policy sits on

    TSS

    Tamamlayıcı ve Destekleyici Sağlık Sigortası — complementary product that pays private-hospital difference fees

    1 Jan 2026

    Date SEDDK’s renewed private-health rules, including standardised ÖBYG offers, took effect

    SUT

    Health Implementation Communiqué — the tariff book that prices SGK-contracted private care

    Named accounts

    Top health insurance companies in Turkey

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against SEDDK — private health insurance (TSS/ÖSS) supervision, with SGK as the public tariff payer (as of 2026-09-04).
    #CompanyHQ
    01Social Security Institution (SGK)Ankara
    02SEDDK (Insurance and Private Pension Regulation and Supervision Authority)Istanbul
    03Allianz TürkiyeIstanbul
    04Anadolu SigortaIstanbul
    05AksigortaIstanbul
    06Mapfre SigortaIstanbul
    07Türkiye SigortaIstanbul
    08Acıbadem SigortaIstanbul
    09Groupama SigortaIstanbul
    10Sompo SigortaIstanbul
    11Acıbadem Healthcare Group — network accountIstanbul
    12MLP Care (Medical Park / Liv) — network accountIstanbul
    13Memorial Healthcare Group — network accountIstanbul
    14Ministry of Health — city hospitals as SGK sitesAnkara
    15Insurance Association of Turkey (TSB) — health committeeIstanbul
    16Sigorta Bilgi ve Gözetim Merkezi (SBM)Istanbul

    Primary research

    These are the payers we interview in Turkey

    Building a market-access or reimbursement case in Turkey? BioNixus runs payer, TPA and employer interviews plus willingness-to-cover studies. Proposal within 48 hours.

    Planning research in Turkey?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in Turkey (2026)

    How the market is structured

    How SGK tariffs and TSS policies share a Turkish hospital bill

    A typical private-hospital admission in Istanbul produces two invoices in spirit even when the patient sees one desk. SGK pays the contracted SUT tariff, with a regulated difference fee the hospital may charge on top. TSS is the product that picks up that difference, provided the hospital is in the insurer’s network and waiting periods have passed. Full ÖSS products go further and can treat the stay as a private event, which is why they cost more and why SEDDK now polices lifetime-renewal promises more tightly. Allianz, Anadolu, Aksigorta and Mapfre compete on network breadth — whether Liv, Acıbadem, Memorial and the Medical Park tier are in — and on how harshly they apply medical underwriting. Türkiye Sigorta, the state-backed composite, adds public-adjacent capacity. Acıbadem Sigorta is the writer born from a hospital group, which is a useful reminder that in Turkey the operator and the payer can share a brand. City hospitals and university hospitals still run mostly on SGK alone. A specialty-drug launch is therefore an SGK protocol-and-SUT fight first, and a TSS/ÖSS network fight only for the slice of patients who use private chains. Medical tourism is cash or international insurance and should not be mixed into a TSS forecast.

    Local

    Anadolu, Aksigorta, Acıbadem Sigorta and Türkiye Sigorta — domestic and state-backed writers of TSS and ÖSS — plus TSB as the industry room.

    • Anadolu Sigorta
    • Aksigorta
    • Acıbadem Sigorta
    • Insurance Association of Turkey (TSB) — health committee

    Multinational

    Allianz, Mapfre, Groupama and Sompo, which hold large complementary books on Turkish licences.

    • Allianz Türkiye
    • Mapfre Sigorta
    • Groupama Sigorta
    • Sompo Sigorta

    Regional

    Turkish writers themselves export little medical risk; the regional story here is hospital groups (IHH/Acıbadem) that sit on both operator and insurer sides.

    TPAs, regulators & public payers

    SGK and SEDDK as the two pillars, SBM as the data utility, city hospitals as SGK-only sites, and Acıbadem, MLP Care and Memorial as the networks TSS is selling.

    • Social Security Institution (SGK)
    • SEDDK (Insurance and Private Pension Regulation and Supervision Authority)
    • Türkiye Sigorta
    • Acıbadem Healthcare Group — network account
    • MLP Care (Medical Park / Liv) — network account
    • Memorial Healthcare Group — network account
    • Ministry of Health — city hospitals as SGK sites
    • Sigorta Bilgi ve Gözetim Merkezi (SBM)

    What is moving

    What is moving health insurance in Turkey

    TSS as the mass private product

    Complementary cover is how middle-income families buy private-hospital comfort without leaving SGK. Network design at Allianz and Anadolu therefore steers a lot of elective volume.

    SEDDK’s 2026 consumer-rights rulebook

    Standardised lifetime-renewal offers and portable waiting-period rights make TSS stickier and make switching among writers more plausible — a headache and an opportunity for hospital network teams.

    Private chains living on a two-payer bill

    Medical Park can fill a ward on SUT; Liv and Acıbadem need the TSS/ÖSS top-up. Formulary and difference-fee fights happen at that seam.

    SGK still deciding specialty-drug volume

    A SUT listing and a city-hospital protocol move more vials than any complementary card. Private insurance is the second conversation, not the first.

    BioNixus fieldwork

    How BioNixus studies health insurance companies in Turkey

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Turkey:
    • Bill-split interviews at Acıbadem, Liv and Medical Park desks in Istanbul on how a single admission is coded to SUT versus TSS.
    • Broker interviews in Levent and Ankara on how SEDDK’s 2026 ÖBYG rules changed TSS tenders for corporate books.
    • Specialty-drug pathway work in Ankara city hospitals that starts from the SUT protocol list rather than from a complementary card.
    • Network-inclusion interviews with Memorial and Anadolu Sigorta teams on whether an oncology ward is actually open to a mid-tier TSS product.

    Healthcare market research in Turkey

    Questions

    Frequently Asked Questions

    What is TSS and who can buy it?

    Tamamlayıcı ve Destekleyici Sağlık Sigortası. The buyer must already be an SGK general-health beneficiary. The product pays private-hospital difference fees and some extras inside a named network, under SEDDK rules.

    What changed on 1 January 2026?

    SEDDK’s renewed private-health framework, including a requirement to offer a lifetime-renewal (ÖBYG) contract to eligible people under 60, tighter waiting-period rules and more portable rights. Read the Authority’s guide, do not rely on an old broker one-pager.

    Does SGK pay private hospitals?

    Yes, when the hospital is contracted, at SUT tariffs, with a regulated difference fee. That is why TSS exists. City hospitals and university hospitals run far more of their book on SGK alone.

    Which writers and which hospital groups belong on a first map?

    SGK first. Then Allianz, Anadolu, Aksigorta, Mapfre, Türkiye Sigorta and Acıbadem Sigorta. Then Acıbadem, MLP Care and Memorial as the networks those cards sell.

    What does BioNixus study about Turkish health insurers?

    TSS versus SUT bill-split interviews at Acıbadem, Liv and Medical Park in Istanbul and Ankara; SEDDK-rule implementation checks with brokers; and specialty-drug pathway work that starts with the SUT code, not with the complementary card.

    Is this a ranking of Turkish health insurers by TSS premiums?

    It is a two-layer map. SGK, SEDDK, complementary writers and the hospital groups they credential sit together so a planner can see which invoice a vial actually sits on. Role sets the order, not a premium league.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Turkey. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: SEDDK — private health insurance (TSS/ÖSS) supervision, with SGK as the public tariff payer, consulted 2026-09-04. Company classification (Local / MNC / Regional / tpas, regulators & public payers) reflects ownership and role in Turkey, not size.

    • SEDDK Özel Sağlık Sigortalarında Yeni Dönem Bilgilendirme Rehberi and related 2026 rulebook materials
    • SGK Health Implementation Communiqué (SUT) public materials
    • Company materials of Allianz Türkiye, Anadolu Sigorta, Aksigorta, Mapfre, Türkiye Sigorta and Acıbadem Sigorta; BIST disclosures of MLP Care
    • BioNixus Turkey payer, TSS and hospital-billing fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need payer and reimbursement data in Turkey?

    Coverage rules, formulary influence and price sensitivity by insurer — fielded with medical directors and claims teams.

    Planning research in Turkey?

    Primary research, market access & HEOR. Proposals within 48 hours.